HOYA Corporation
7741
Rang in aandelen
#414
Globally recognized as a med-tech innovator, HOYA Corporation is a prominent... Globally recognized as a med-tech innovator, HOYA Corporation is a prominent provider of advanced technology and healthcare solutions worldwide. Its comprehensive portfolio of life care products encompasses vision correction items such as eyeglasses and contact lenses, alongside sophisticated medical devices including endoscopes, intraocular lenses, and surgical instruments for laparoscopic procedures. HOYA also supplies automated endoscope cleaning systems and various medical essentials like prosthetic ceramic fillers and metallic implants. Complementing its medical offerings, the company operates Eyecity, a specialized retail chain for contact lenses. In the realm of information technology, HOYA manufactures crucial components such as mask blanks and photomasks for semiconductor and liquid crystal display fabrication, as well as glass disks for hard disk drives. Its imaging products segment includes optical glasses, specialized lenses, colored glass filters, and laser/UV light source equipment. Furthermore, the company extends its expertise into software and cloud services, offering ReadSpeaker, a speech synthesis application, and cloud platforms like Kinnosuke for time and attendance management, and Yonosuke for electronic payslip distribution. HOYA Corporation, established in 1941, is headquartered in Tokyo, Japan.
Aandeelprijs
$170.48
Marktkapitalisatie
$57.03B
Verandering (1 dag)
1.60%
Verandering (1 jaar)
12.48%
Land
JP
Handel HOYA Corporation (7741)
Categorie
Healthcare
Winst voor HOYA Corporation (7741)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van HOYA Corporation bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van HOYA Corporation van 2001 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2025 | $1.73B | 10.96% |
| 2024 | $1.56B | -3.85% |
| 2023 | $1.63B | -6.07% |
| 2022 | $1.73B | 20.38% |
| 2021 | $1.44B | 4.95% |
| 2020 | $1.37B | 5.11% |
| 2019 | $1.30B | 11.44% |
| 2018 | $1.17B | 17.56% |
| 2017 | $994.72M | -6.03% |
| 2016 | $1.06B | 7.37% |
| 2015 | $985.90M | 18.95% |
| 2014 | $828.82M | -12.61% |
| 2013 | $948.37M | 45.65% |
| 2012 | $651.14M | -14.66% |
| 2011 | $763.00M | 41.14% |
| 2010 | $540.59M | 20.74% |
| 2009 | $447.73M | -52.78% |
| 2008 | $948.20M | 4.41% |
| 2007 | $908.13M | 9.72% |
| 2006 | $827.68M | -9.00% |
| 2005 | $909.58M | 13.48% |
| 2004 | $801.51M | 229.71% |
| 2003 | $243.09M | -14.30% |
| 2002 | $283.65M | 12.92% |
| 2001 | $251.20M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $3.62B | - |
US
|
|
| $4.11B | - |
FR
|
|
| $1.59B | - |
US
|
|
| - | - |
CH
|
|
| - | - |
US
|
